NAYA NAYA Biosciences Inc.: Company Short-Term Debts

Symbol and logo of brand NAYA Biosciences (NAYA)

The daily price chart for NAYA Biosciences (NAYA) with the -0.01 indicator reflects the performance of a company developing advanced antibodies to combat tumors. The brand is recognized as a technological visionary in targeted therapy, which continues to attract capital. Management is focused on discovering new drug formulas and securing financing. Due to its independence from global crises and the constant demand for medicine, the business serves as a stable defensive asset.

NAYA NAYA Biosciences Inc Company Short-Term Loans and Borrowings (07/04/2022 - 04/28/2025)

NAYA (NAYA Biosciences Corp): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price NAYA Biosciences Inc.|NAYA - Consensus Target
- company stock capitalization data:
Market Capitalization NAYA Biosciences Inc.|NAYA - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share NAYA Biosciences|NAYA - Accounting Value of Company|Market Cap to Net Assets Ratio nayabiosciences.com|NAYA - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital NAYA Biosciences|NAYA - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio NAYA Biosciences|NAYA - Company Aggregate Debts|Debt to Book Capitalization Ratio NAYA Biosciences Inc.|NAYA - Company Long-Term Loans and Borrowings|Company Short-Term Debts NAYA Biosciences|Quick Liquidity nayabiosciences.com
- earnings and multiples data:
NAYA - Company Profit
Analysis of all company metrics:NAYA - NAYA Biosciences Inc.
Manufactured products of nayabiosciences.com

The specifics of NAYA Biosciences immunotherapy development amid geopolitical risks necessitate strict liquidity control to ensure the continuity of international clinical trials. Analyzing the book value of short-term debt, investors compare obligations maturing within one year against operating cash flows to assess default risk and the company's financial flexibility within a high-risk investment class.

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|candeltx.com (CADL) - Company Short-Term Debt|Accuray Inc - Company Short-Term Loans and Borrowings|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Short-Term Debt Actuate Therapeutics Inc ACTU|Company Short-Term Debt Citius Oncology, Inc. (CTOR)|tuhurabio.com - Company Short-Term Indebtedness|Company Short-Term Debts TARA (Protara Therapeutics, Inc.)|Company Short-Term Debts Fate Therapeutics Inc FATE|WHWK: Company Current Liabilities|Short-Term Debt TScan Therapeutics|CSBR: Company Short-Term Debts|XBiotech (XBIT) - Company Short-Term Debts|Company Current Liabilities CVM|OSTX: Company Short-Term Loans and Borrowings|Company Short-Term Debts RADX|Company Short-Term Debt ARTV (artivabio.com)|Company Short-Term Debts ANL (Adlai Nortye)|Short-Term Debt Volume verupharma.com (VERU)|TPST - Company Short-Term Debt|Short-Term Debt Xilio Therapeutics, Inc.|renovarobio.com (RENB) - Company Short-Term Debt|MURA - Short-Term Debt Volume|KAPA (Kairos Pharma Limited) - Company Short-Term Debts|Company Current Liabilities OnKure (OKUR)|Company Short-Term Debts GDTC|Short-Term Debt Volume curis.com|Company Short-Term Debts APLM (Apollomics)|Tharimmune Corporation (THAR) - Short-Term Debt|ADVB - Company Short-Term Debt|GNPX (genprex.com) - Company Short-Term Indebtedness|CLDI: Company Short-Term Debts|Company Current Liabilities sunshinebiopharma.com|XBIO (Xenetic Biosciences Inc.) - Company Short-Term Debts|Short-Term Debt Salarius Pharma SLRX|Company Short-Term Debt Purple Biotech (PPBT)|Short-Term Debt Volume aoncology.com|Company Short-Term Debt BeiGene BGNE|CKPT: Company Short-Term Indebtedness|Elevation Oncology - Company Short-Term Debts|ICAD - Company Short-Term Debts|IKNA (ikenaoncology.com) - Company Current Liabilities|Short-Term Debt notablelabs.com (NTBL)|VIRX (Viracta Therapeutics Inc.) - Company Short-Term Debts|Company Short-Term Debts MorphoSys Inc|Company Short-Term Debts AAPGV